Safety Evaluation of a Potential Anti-Rheumatoid Arthritis Candidate, Levamisole
This study provides valuable preclinical data on the safety and efficacy of LVM, laying the groundwork for future clinical applications and potentially offering a safer and more effective treatment option for RA patients.
Authors
- Jun-Xiang Wang (ORCID: https://orcid.org/0009-0000-0330-5916)
- Xiangbin Yu (ORCID: https://orcid.org/0000-0003-3502-9578)
- Yiqun Liao (ORCID: https://orcid.org/0000-0003-2585-0688)
- Yingxue Yan
- Hanlu Zheng
- Jiahui Zhang (ORCID: https://orcid.org/0000-0002-9059-7546)
- Can Dai (ORCID: https://orcid.org/0000-0001-6185-3590)
- Yue Yu (ORCID: https://orcid.org/0000-0001-7905-6733)
- Mu Guo (ORCID: https://orcid.org/0009-0004-6462-0687)
- Nengfu Qiu
- Zhaolong Lin
- Weirui Huang
Institutions
- Fujian University of Traditional Chinese Medicine (CN)
- Fujian Medical University (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/jir.s477013
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fujian Provincial Department of Science and Technology
- Putian University
- Fujian Medical University